Dec 12, 2024 Posted on 12 December 202412 December 2024 Sanofi’s combo vaccines gain FDA fast track designation
Oct 21, 2024 Posted on 21 October 20246 November 2024 Sanofi in ‘exclusive negotiations’ to sell 50% stake in €16B consumer health unit Opella
Oct 01, 2024 Posted on 1 October 20244 October 2024 Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo